SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-16-110217
Filing Date
2016-06-28
Accepted
2016-06-28 15:28:52
Documents
1
Period of Report
2016-06-24

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v443126_4.html 4  
1 OWNERSHIP DOCUMENT v443126_4.xml 4 4160
  Complete submission text file 0001144204-16-110217.txt   5601
Mailing Address 170 HARBOR WAY SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY SUITE 300 SOUTH SAN FRANCISCO CA 94080 650 474 8200
THRESHOLD PHARMACEUTICALS INC (Issuer) CIK: 0001183765 (see all company filings)

IRS No.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O THRESHOLD PHARMACEUTICALS, INC. 170 HARBOR WAY SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address
Parkinson David Ross (Reporting) CIK: 0001451935 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32979 | Film No.: 161735931